Mutation Screening of the ALS2 Gene in Sporadic and Familial Amyotrophic Lateral Sclerosis
Authors:
- Collette K. HandCHCollette K. Hand
- Rebecca S. DevonRDRebecca S. Devon
- Francois Gros-LouisFGFrancois Gros-Louis
- Daniel RochefortDRDaniel Rochefort
- Jawad KhorisJKJawad Khoris
- Vincent MeiningerVMVincent Meininger
- Jean-Pierre BouchardJBJean-Pierre Bouchard
- William CamuWCWilliam Camu
- Michael R. HaydenMHMichael R. Hayden
- Guy A. RouleauGRGuy A. Rouleau
Open Access
- 1 December 2003
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 60 (12) , 1768-1771
Abstract
AMYOTROPHIC LATERAL sclerosis (ALS) is an adult-onset neurodegenerative disorder characterized by the death of motor neurons in the cortex, brainstem, and spinal cord, resulting in progressive paralysis and death, usually within 3 to 5 years of symptom onset.1,2 Most ALS cases are sporadic, without any family history. Approximately 15% to 20% of cases are familial, and within these lie several distinct forms of the disease.Keywords
This publication has 1 reference indexed in Scilit: